Literature DB >> 10842157

Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity.

J M Rhodes1, J S Cho, P Gloviczki, G Mozes, R Rolle, V M Miller.   

Abstract

PURPOSE: Thrombolysis protects the structural and functional integrity of vein wall in an experimental model of acute deep venous thrombosis (DVT) immediately after treatment, but late sequelae have not been studied. We designed experiments to compare the effects of thrombolysis and surgical thrombectomy at 4 weeks after the treatment of DVT.
METHODS: DVT was produced bilaterally in male mongrel dogs by proximal and distal femoral vein ligation. Five dogs underwent sham operation. After 48 hours, the ligatures were removed, and the thrombosis was treated with either Fogarty balloon catheter thrombectomy (shear force, 60 g; n = 6) or catheter-directed urokinase infusion (4000 U/min for 90 minutes; n = 6). At 4 weeks, patency and valvular competence were determined by duplex ultrasound scanning. Thrombogenicity was studied by the measurement of radiolabeled fibrin and platelet deposition. Veins were explanted and prepared for histologic examination, scanning electron microscopy, and functional studies in organ chambers.
RESULTS: All veins were patent at 1 month. Recanalized thrombus was observed histologically in four (66%) thrombectomized veins, one (17%) thrombolyzed vein, and none of the sham-operated veins (P =.04). Scanning electron microscopy demonstrated similar luminal endothelial cell loss (11%-25%) in all three groups. Platelet and fibrin depositions were not different among groups. Valvular incompetence (reflux duration, >0.5 sec) did not differ significantly in the groups (thrombectomized veins, 2 of 12 (17%); thrombolyzed veins, 0 of 12 (0%); P = NS). In organ chamber studies, endothelium-dependent relaxations to calcium ionophore, but not adenosine diphosphate, were inhibited by an antagonist of nitric oxide production after thrombectomy (P <.05, thrombectomy vs sham- and thrombolysis-treated veins). All veins relaxed to exogenous nitric oxide.
CONCLUSION: Both thrombectomy and thrombolysis restored patency and achieved similar valvular competence. Surgical thrombectomy, however, resulted in more residual thrombus and contributed to changes in endothelium-mediated relaxations at 4 weeks. Thrombolysis maintained both structural integrity and endothelial function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10842157     DOI: 10.1067/mva.2000.104421

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  8 in total

1.  Low-dose, once-daily, intraclot injections of alteplase for treatment of acute deep venous thrombosis.

Authors:  Richard Chang; McDonald K Horne; Thomas H Shawker; Anthony W Kam; Enn Alexandria Chen; Galen O Joe; Willie L Ching; Edie Mao; David A Wyrick; Jay N Lozier
Journal:  J Vasc Interv Radiol       Date:  2011-06-12       Impact factor: 3.464

2.  Rheolytic pharmacomechanical thrombectomy in experimental chronic deep vein thrombosis: effect of L-arginine on thrombogenicity and endothelial vasomotor function.

Authors:  Peter H Lin; Tamuru Okada; James L Steinberg; Wei Zhou; Hosam F El Sayed; Anish Rawat; Panos Kougias; Qizhi Yao; Changyi Chen
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

3.  Catheter-directed thrombolysis with conventional aspiration thrombectomy for lower extremity deep vein thrombosis.

Authors:  Yong Sun Jeon; Yong Han Yoon; Joung Ym Cho; Wan Ki Baek; Kwang Ho Kim; Kee Chun Hong; Joung Taek Kim
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

4.  A novel hollow and perforated flexible wire allows the safe and effective local application of thrombolytic therapy in a mouse model of deep vein thrombosis.

Authors:  Thilo Witsch; Maximilian Mauler; Nadine Herr; Daniela Stallmann; Christoph Bode; Christoph Hehrlein; Daniel Duerschmied
Journal:  J Thromb Thrombolysis       Date:  2014-05       Impact factor: 2.300

5.  Effects of low frequency ultrasound on some properties of fibrinogen and its plasminolysis.

Authors:  Eugene A Cherniavsky; Igor S Strakha; Igor E Adzerikho; Vladimir M Shkumatov
Journal:  BMC Biochem       Date:  2011-11-23       Impact factor: 4.059

6.  Thrombectomy Combined with Indwelling-catheter Thrombolysis is more Effective than Pure Thrombectomy for the Treatment of Lower Extremity Deep Venous Thrombosis.

Authors:  Wenli Wang; Yanfang Wu; Tao Fang; Dunyuan Xu
Journal:  Open Med (Wars)       Date:  2017-06-03

7.  2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 6: Defining rational use of thrombolytics.

Authors:  Claire R Sharp; Marie-Claude Blais; Corrin J Boyd; Benjamin M Brainard; Daniel L Chan; Armelle de Laforcade; Robert Goggs; Julien Guillaumin; Alex Lynch; Erin Mays; Duana McBride; Tommaso Rosati; Elizabeth A Rozanski
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2022-07

8.  Clinical application for DSA combined with a double-chamber Fogarty catheter in the treatment of venous crisis.

Authors:  Xiaodong Li; Xiaowei Yan; Haijun Jiang; Rui Gu; Qiang Xie; Changyu Yu; Pei Wang
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-11-25       Impact factor: 1.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.